lane
Uploaded by
9 SLIDES
209 VIEWS
90LIKES

Enhancing Bermuda's Drug Information Network: 2013 Annual Meeting Insights

DESCRIPTION

The 2013 Annual Meeting of the Bermuda Drug Information Network (BerDIN) focused on new developments and expanded areas of data collection and analysis. Presenters shared insights on agency roles in informing the drug situation in Bermuda, types of data provided, frequency and process of data submission, and challenges faced in reporting. Valuable recommendations for improving data reliability and suggestions for BerDIN's future directions were discussed. This meeting serves as a crucial touchpoint for enhancing collaboration and data-driven strategies in addressing drug-related issues in Bermuda.

1 / 9

Download Presentation

Enhancing Bermuda's Drug Information Network: 2013 Annual Meeting Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Playing audio...

  1. 2013 ANNUAL MEETING OF THE BERMUDA DRUG INFORMATION NETWORK (BerDIN) NEW DEVELOPMENTS & EXPANDED AREAS Update from Insert Name of Your Agency PRESENTED BY: Insert Name of Presenter Insert Title/Position October 24th & 25th, 2013

  2. YOUR ROLE • What is your role in the Network? i.e., how do you see your agency as informing the drug situation in Bermuda? • Click to add text

  3. DATA PROVIDED • What type of data or indicators are provided to the DNDC for compilation? (include the year for which data was last submitted, level of detail, i.e., age, gender, drug of choice) • Click to add text

  4. OTHER RELEVANT DATA • Are there other data produced by your agency, not currently compiled by the Network, that may be relevant in informing the drug situation? • Click to add text

  5. DATA SUBMISSION • Frequency (When is the Data Submitted?) • Click to add text • Process (How is the Data Submitted?) • Click to add text

  6. CHALLENGES & LIMITATIONS OR REPORTING ISSUES • What are the difficulties encountered, if any, in providing the required data? • Click to add text

  7. NEEDS • What support (of any kind) do you need in reliably providing data? • Click to add text

  8. RECOMMENDATIONS • How can the (your) process of providing data be enhanced? • Click to add text • What would you suggest for the BeDIN going forward? • Click to add text

  9. OTHER INFORMATION • Anything else to share with the Network? • Click to add text

More Related